Napo Pharmaceuticals, Inc.
185 Berry Street
Suite 1300
South San Francisco
California
94080
United States
Tel: 415-371-8300
Fax: 415-371-8311
Website: http://www.napopharma.com/
Email: info@napopharma.com
105 articles about Napo Pharmaceuticals, Inc.
-
Salix Pharmaceuticals, Ltd. In-Licenses Crofelemer from Napo Pharmaceuticals, Inc.
12/10/2008
-
Napo Pharmaceuticals, Inc. Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases
9/26/2008
-
Napo Pharmaceuticals, Inc. Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
9/22/2008
-
Novel Drug Development Alliance Between Napo Pharmaceuticals, Inc. and Direct Relief International Targets Global Implications of Pediatric Diarrhea
9/19/2008
-
Napo Pharmaceuticals, Inc. Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea
4/11/2008
-
Napo Pharmaceuticals, Inc. Receives Enteric Coated Formulation of Crofelemer Patent from United States Patent Office
2/6/2008
-
Napo Pharmaceuticals, Inc. Announces Annual Meeting Results
10/23/2007
-
Napo Pharmaceuticals, Inc. Obtains Special Protocol Assessment Agreement From FDA for Crofelemer in HIV/AIDS Diarrhea Assessment
7/3/2007
-
Napo Pharmaceuticals, Inc. Appoints Thomas Van Dyck as Non-Executive Director
6/14/2007
-
Napo Pharmaceuticals, Inc. Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from 2006 Presented at Digestive Disease Week in Washington, D.C.
5/23/2007
-
Napo Pharmaceuticals, Inc. Preliminary Results For The Year Ended December 31, 2006
3/30/2007
-
Napo Pharmaceuticals, Inc. Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment
3/14/2007
-
Napo Pharmaceuticals, Inc. Release: Appointment of Jack Van Hulst as Non-Executive Director
3/6/2007
-
Napo Pharmaceuticals, Inc. Enters Plant Screening Agreement With Nicholas Piramal India Limited For Diabetes
1/22/2007
-
Napo Pharmaceuticals, Inc. Appoints Chief Operating Officer
1/15/2007
-
Napo Pharmaceuticals, Inc. Appoints Chief Operating Officer
1/12/2007
-
Napo Pharmaceuticals, Inc. Application For Admission
1/10/2007
-
Napo Pharmaceuticals, Inc. Receives Commitments For A Private Placement Of Common Shares And Enters Into Binding Letter Of Intent For Intellectual Property License
1/9/2007
-
Napo Pharmaceuticals, Inc. Completes Feasibility Assessment For Chronic Diarrhoea In People Living With HIV/AIDS (CRO-HIV)
12/20/2006
-
Napo Pharmaceuticals, Inc. Announces The Successful Production Of Crofelemer Active Pharmaceutical Ingredient
11/17/2006